The Bull Rankings scorecard — our quality-growth score is 53.3 / 100, built from three pillars scored 0–100: Quality 71, Growth 69, Value 31 (valuation is judged against sector peers). At today's price, our reverse-DCF read says the market is implicitly betting on free-cash-flow growth of about 5% a year next year, fading to 4% a year by year ten — a gauge of how much optimism is already in the stock.
The thesis
JBS’s price is a P/E 11.1 – the cheapest decile in Consumer Defensive, roughly the 10th percentile. That alone signals the market is under‑pricing the company relative to peers. Yet the quality‑growth score of 53.3 tells a different story: the business scores 71 on Quality and 69 on Growth, but only 31 on Value. Our model therefore sees a solid, high‑margin operation that is growing, but the current price sits on the expensive side of the Value ranking. The single sharpest argument for owning JBS today is that the market has not yet priced in the quality of its operations and the upside from its growth trajectory. Three figures back this: a ROE of 23.4%, a profit margin of 2.6% that is stable, and free‑cash‑flow of $833m in FY 2025‑12‑31. These numbers show a company that is generating cash and returning it to shareholders at a healthy rate, while the P/E suggests the market is still waiting for that story to unfold.
What the business actually is
JBS processes animal proteins—beef, pork, lamb, and poultry—across the globe. It markets prepared foods under brands such as Seara, Doriana, Pilgrim’s, Moy Park, Primo, Friboi, Maturatta, Swift, Ozo, and Adaptable Meals. Beyond meat, it operates in leather, collagen, hygiene and beauty products, metal packaging, and biodiesel. The revenue engine is driven by the prepared foods segment, which benefits from higher margins and repeat customers, while the core meat processing remains a volume‑heavy, low‑margin activity. The diversity of brands and product lines gives JBS a broad customer base, from supermarkets to food service operators, ensuring steady demand.
Why it can (or can't) keep compounding
The moat lies in scale and integration. JBS’s debt‑to‑equity of 2.83 reflects a leveraged but manageable capital structure, allowing it to invest in upstream and downstream assets. The profit margin of 2.6% is modest, but the company’s ROE of 23.4% indicates it turns that margin into shareholder value efficiently. Competitors would need to replicate JBS’s global supply chain, brand portfolio, and integrated processing facilities, a capital‑intensive endeavor that would take years to match.
The valuation question
The market’s P/E of 11.1 is cheap by sector standards, yet our reverse‑DCF shows the price implies a free‑cash‑flow growth of 5% in year 1, tapering to 4% by year 10. That starting rate is lower than the trailing revenue growth of 11.7%. In plain terms, the market is pricing in a slower growth trajectory than the business has just delivered. This is a pessimism bias: the price assumes JBS will not sustain the 11.7% revenue growth for the next decade. If the company can maintain or even accelerate that growth, the current valuation is a bargain; if it falters, the price is already reflecting that downside.
The bear case
The weakest pillar in our model is Value at 31. A Value score that low means the stock is expensive relative to sector peers and its own P/E history. Coupled with a debt‑to‑equity of 2.83, the company’s leverage could become a drag if commodity prices rise or if regulatory costs increase. A concrete signal that would confirm this scenario is a decline in free‑cash‑flow below $833m or a profit margin dropping below 2.6%. Such a shift would erode the cash cushion that supports dividends and buybacks, and would push the P/E higher, eroding the current cheapness.
What would change our mind
- Free‑cash‑flow falling below $833m would indicate the company is no longer generating the cash it once did, weakening the quality pillar.
- Profit margin slipping below 2.6% would suggest cost pressures are eroding the business’s core profitability, undermining the growth narrative.
- Debt‑to‑equity rising above 2.83 would signal increasing leverage, raising the risk of financial distress and potentially forcing asset sales or dividend cuts.
If any of these thresholds are breached, the quality‑growth score would drop, the Value pillar would worsen, and the market would likely reprice JBS downward, turning the current thesis on its head.